Zelira Therapeutics Limited (ASX:ZLD)

Zelira Therapeutics Revenue

Zelira Therapeutics had revenue of 655.00 AUD in the half year ending December 31, 2024, a decrease of -99.15%. This brings the company's revenue in the last twelve months to 40.88K, down -85.34% year-over-year. In the fiscal year ending June 30, 2024, Zelira Therapeutics had annual revenue of 94.95K, down -68.47%.

• Revenue (ttm): 40.88K
• Revenue Growth: -85.34%
• P/S Ratio: 119.31
• Revenue / Employee: n/a
• Employees: n/a
• Market Cap: 4.88M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Jun 30, 2024	94.95K	-206.17K	-68.47%
Jun 30, 2023	301.12K	-1.24M	-80.45%
Jun 30, 2022	1.54M	877.31K	132.26%
Jun 30, 2021	663.32K	-	-
Jun 30, 2020	-	-	-